期刊
ARTHRITIS RESEARCH & THERAPY
卷 6, 期 4, 页码 174-177出版社
BMC
DOI: 10.1186/ar1202
关键词
autoimmune disease; interleukin-15; memory T cells; rheumatoid arthritis
类别
资金
- NATIONAL CANCER INSTITUTE [ZIASC004002, Z01SC004002] Funding Source: NIH RePORTER
Interleukin (IL)-15 is a dangerous inflammatory cytokine that induces tumor-necrosis factor-alpha, IL-1beta and inflammatory chemokines. It inhibits self-tolerance mediated by IL-2 mediated activation-induced cell death and facilitates maintenance of CD8(+) memory T-cell survival including that of self-directed memory cells. Disordered IL-15 expression has been reported in patients with an array of inflammatory autoimmune diseases. A series of therapeutic agents that inhibit IL-15 action have been introduced, including the soluble IL-15 receptor (IL-15R) alpha chain, mutant IL-15, and antibodies directed against the IL-15 cytokine and against the IL-2R/IL-15R beta subunit used by IL-2 and IL-15.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据